Spruce Biosciences (SPRB) Enterprise Value (2022 - 2025)
Spruce Biosciences (SPRB) has disclosed Enterprise Value for 4 consecutive years, with -$48.9 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value fell 26.2% to -$48.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.9 million, a 26.2% decrease, with the full-year FY2025 number at -$48.9 million, down 26.2% from a year prior.
- Enterprise Value was -$48.9 million for Q4 2025 at Spruce Biosciences, down from -$10.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$10.7 million in Q3 2025 to a low of -$118.6 million in Q1 2023.
- A 4-year average of -$69.8 million and a median of -$80.1 million in 2022 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: fell 29.82% in 2023, then surged 82.23% in 2025.
- Spruce Biosciences' Enterprise Value stood at -$79.1 million in 2022, then fell by 21.83% to -$96.3 million in 2023, then soared by 59.77% to -$38.8 million in 2024, then fell by 26.2% to -$48.9 million in 2025.
- Per Business Quant, the three most recent readings for SPRB's Enterprise Value are -$48.9 million (Q4 2025), -$10.7 million (Q3 2025), and -$16.4 million (Q2 2025).